Defense World
15 Mar 2026, 05:40 UTC · 34w ago
Verdict
Headline leans bearish. We score ACXP +0.30 across two claims.
Score contradicts the headline.
Leans bearish
From its wording — no explicit rating
+0.30moderately bullish
More positive than 59% of ticker scores this week
Top 2 movers · tap to explore
What the story claims
2 claims · scored −1 bearish … +1 bullish
Acurx Pharmaceuticals experienced a 21.8% decline in short interest between February 12th and February 27th.
More positive than 49% of claims this week
As of February 27th, 2.8% of Acurx Pharmaceuticals' shares are short sold.
So whatA short interest ratio of 2.8% is very low and unlikely to trigger significant volatility or a short squeeze.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
More positive than 59% of ticker scores this week
A significant decline in short interest is generally viewed as a bullish signal by investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
5h ago
−71.6%
Price is moving against the score
$1.10 vs $3.88 close before publication (Mar 13) · not market-adjusted
ACXP chart →
